Moreover, the finding that inhibition of Cdc42 results in loss of elongated, mesenchymal morphology [40], which we also observed following AZA197 treatment, further strengthens the function of AZA197 as a Cdc42 inhibitor and the tumor promoting role of Cdc42 in colon cancer. This evidence concerns the gene CDC42 and neoplasm.